Driehaus Capital Management LLC Mirum Pharmaceuticals, Inc. Transaction History

Driehaus Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$13.95 - $20.18 $5.21 Million - $7.53 Million	-373,175 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$15.84 - $20.6 $2.27 Million - $2.95 Million	-143,128 Reduced 27.72%	373,175 $6.45 Million
Q1 2021 May 17, 2021	SELL	$16.29 - $21.92 $456,739 - $614,592	-28,038 Reduced 5.15%	516,303 $10.2 Million
Q4 2020 Feb 16, 2021	BUY	$15.75 - $25.45 $6.84 Million - $11.1 Million	434,341 Added 394.86%	544,341 $9.5 Million
Q3 2020 Nov 16, 2020	BUY	$18.4 - $26.59 $368,000 - $531,800	20,000 Added 22.22%	110,000 $2.12 Million
Q2 2020 Aug 14, 2020	BUY	$11.51 - $20.97 $1.04 Million - $1.89 Million	90,000 New	90,000 $1.75 Million

208

54M

64.1K

117K

Ticker MIRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,751,700
Market Cap $1.84B
Description
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Driehaus Capital Management LLC with notifications on news.